Pay in 4 interest-free payments of $6.33 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
If response is inadequate after the FDA-recommended evaluation period at therapeutic doses, consider switching to an alternative agent or referring for surgical revision evaluation in appropriate candidates
A new family with an activating mutation (G431S) in the TSH receptor gene: A phenotype discussion and review of the literature
Challenges in the management of SARS-CoV2 infection: the role of oral bacteriotherapy as complementary therapeutic strategy to avoid the progression of COVID-19
At RazorMetrics, we help plan sponsors and PBMs navigate these industry shifts by providing data-driven solutions that maximize savings and optimize prescription choices
US$ 25.78
US$ 20.75
US$ 23.09
US$ 28.30
US$ 26.06
US$ 20.43
US$ 28.95
US$ 29.64
US$ 27.05
US$ 22.00
